$104.91
+0 (+0%)
At Close: Jun 03, 2026
Here's Why Investors Should Buy Exact Sciences (EXAS) Stock
12:02pm, Wednesday, 11'th Jan 2023
Investors are optimistic about Exact Sciences (EXAS) on continued strength across the Screening and Precision Oncology businesses.
Cathie Wood Makes This Molecular Diagnostics Company Top Holding Of Ark Invest's Flagship Fund, Catapulting Past Zoom, Tesla
11:19am, Wednesday, 11'th Jan 2023
Shares of Exact Sciences, Inc. EXAS have been on a tear, having gained over 27% in two sessions this week.
Exact Sciences Corp Stock Price Is Trending Up Here's Why
08:56am, Wednesday, 11'th Jan 2023
Exact Science's stock price is shooting higher this week amid posting upward revisions for its revenue and earnings estimates for this quarter.
Strength Seen in Exact Sciences (EXAS): Can Its 24.7% Jump Turn into More Strength?
02:55pm, Tuesday, 10'th Jan 2023 Zacks Investment Research
Exact Sciences (EXAS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price incre
Is Bionano Genomics (BNGO) Stock Outpacing Its Medical Peers This Year?
02:40pm, Tuesday, 10'th Jan 2023 Zacks Investment Research
Here is how Bionano Genomics, Inc. (BNGO) and Exact Sciences (EXAS) have performed compared to their sector so far this year.
Cathie Wood's Top 5 Stocks See Abysmal Year in 2022
02:14pm, Tuesday, 10'th Jan 2023
As we head into a new year, investors are taking a look at their portfolios to determine which stocks were winners and losers in 2022.
Exact Sciences Breaks Up From This Pattern, Signals Massive Reversal: Is A Bull Cycle In The Cards?
07:06pm, Monday, 09'th Jan 2023 Benzinga
Exact Sciences Corp (NASDAQ: EXAS) gapped up more than 16% to start the trading day on Monday and continued to surge an additional 5.6% before hitting and rejecting a resistance area near $58.50.
The
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
06:42pm, Monday, 09'th Jan 2023 Benzinga
Gainers
CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.
Apexigen, Inc. (NASDAQ: APGN) jumped 111% to
Tesla, Zillow, Albireo Pharma And Some Other Big Stocks Moving Higher On Monday
03:36pm, Monday, 09'th Jan 2023 Benzinga
U.S. stocks traded higher, with the Dow Jones gaining more than 150 points on Monday. Here are some big stocks recording losses in today’s session.
CinCor Pharma, Inc. (NASDAQ: CINC) shares surged
Exact Sciences Corp EXAS gapped up more than 16% to start the trading day on Monday and continued to surge an additional 5.6% before hitting and rejecting a resistance area near $58.50.
Exact Sciences Raises Fourth-Quarter Estimates Above Expectations
12:07pm, Monday, 09'th Jan 2023
EXAS stock jumped as the provider of cancer screening and diagnostic tests raised estimates for its fourth quarter. The post Exact Sciences Raises Fourth-Quarter Estimates Above Expectations appeared
What's Going On With Exact Sciences Stock? - Exact Sciences (NASDAQ:EXAS)
09:48am, Monday, 09'th Jan 2023
Exact Sciences Corp EXAS shares are trading higher Monday after the company announced preliminary fourth-quarter results.
Exact Sciences: Defending ARK's Call Of $140 Per Share By 2027
08:00am, Monday, 09'th Jan 2023
ARK Invest's Cathie Wood believes Exact Sciences (EXAS) can hit $140 per share by 2027. Unlike some other calls, I believe Cathie and ARK are spot-on with EXAS. EXAS is a major holding in both Cathie'
Tesla: Woke Mob Fury - 20 Top Growth Stocks Ranked
12:07pm, Saturday, 07'th Jan 2023 Seeking Alpha
Tesla shares are down 70%, despite the fact that revenues and profits keep growing rapidly. Read more to see why TSLA is a Buy for long-term growth investors.
Investing in Tech ETFs
05:24pm, Friday, 06'th Jan 2023 The Motley Fool
Here's how to get tech exposure without the single-stock risk.
Sign In
Buy EXAS